المؤلفون: Emily C. Cherney (8904614), Liping Zhang (177396), Weiwei Guo (117411), Audris Huang (1436374), David Williams (229939), Steven Seitz (10980140), Weifang Shan (1371309), Xiao Zhu (257280), Johnni Gullo-Brown (2387257), Derrick Maley (10048683), Tai-an Lin (10218930), John T. Hunt (1601446), Christine Huang (743871), Zheng Yang (264955), Celia J. D’Arienzo (1429867), Lorell N. Discenza (9406835), Asoka Ranasinghe (1601449), Mary F. Grubb (4230607), Sarah C. Traeger (1622287), Xin Li (51274), Kathy A. Johnston (1372455), Lisa Kopcho (5941772), Mark Fereshteh (6508499), Kimberly A. Foster (2649784), Kevin Stefanski (1551436), Diane Delpy (10048689), Gopal Dhar (8394876), Aravind Anandam (8394879), Sandeep Mahankali (10218936), Shweta Padmanabhan (4067707), Prabhakar Rajanna (8779820), Venkata Murali (10218939), T. Thanga Mariappan (8958191), Shabeerali Pattasseri (10980143), Roshan Y. Nimje (2222026), Zhenqiu Hong (1745164), James Kempson (1665415), Richard Rampulla (1601455), Arvind Mathur (144120), Anuradha Gupta (1551397), Robert Borzilleri (2102530), Gregory Vite (2853350), Aaron Balog (1371318)

مصطلحات موضوعية: Biophysics, Biochemistry, Cell Biology, Molecular Biology, Pharmacology, Biotechnology, Cancer, Space Science, Chemical Sciences not elsewhere classified, Conformational-Analysis-Guided Disc., metastatic melanoma, mouse xenograft model, cell carcinoma, novel heme-displacing IDO 1 inhibitors, IDO 1 inhibitor, molecules linrodostat, pharmacodynamic activity, oxidative metabolism, fluorine incorporation, compound 29, BMS -986242, quinoline

Relation: https://figshare.com/articles/journal_contribution/Conformational-Analysis-Guided_Discovery_of_2_3-Disubstituted_Pyridine_IDO1_Inhibitors/14791424

الاتاحة: https://doi.org/10.1021/acsmedchemlett.1c00236.s001

المؤلفون: Liping Zhang (177396), Emily C. Cherney (8904614), Xiao Zhu (257280), Tai-an Lin (10218930), Johnni Gullo-Brown (2387257), Derrick Maley (10048683), Kathy Johnston-Allegretto (10218933), Lisa Kopcho (5941772), Mark Fereshteh (6508499), Christine Huang (743871), Xin Li (51274), Sarah C. Traeger (1622287), Gopal Dhar (8394876), Aravind Anandam (8394879), Sandeep Mahankali (10218936), Shweta Padmanabhan (4067707), Prabhakar Rajanna (8779820), Venkata Murali (10218939), Thanga Mariappan (10218942), Robert Borzilleri (2102530), Gregory Vite (2853350), John T. Hunt (1601446), Aaron Balog (1371318)

مصطلحات موضوعية: Biochemistry, Medicine, Cell Biology, Pharmacology, Biotechnology, Developmental Biology, Cancer, Hematology, Virology, Space Science, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, phase III, metastatic melanoma, Potent Inhibitors, cell carcinoma, variety, BMS, imidazopyridine-containing IDO 1 in., IDO 1 inhibitors, IDO 1 inhibitor, small-molecule immunotherapy, heterocyclic isosteres, Indoleamine, IDO 1-selective inhibitor

Relation: https://figshare.com/articles/journal_contribution/Discovery_of_Imidazopyridines_as_Potent_Inhibitors_of_Indoleamine_2_3-Dioxygenase_1_for_Cancer_Immunotherapy/14141796

الاتاحة: https://doi.org/10.1021/acsmedchemlett.1c00014.s001